LISATA THERAPEUTICS, INC. (LSTA) AI Dilution Summary

Cash was $10,443,000 at 2026-06-30 against estimated monthly burn of $883,000. The active funding channel is the H.C. Wainwright ATM, authorised to $9,855,890, with 330,938 shares sold since the program began through 2026-06-30; sales after 2026-06-30 have not yet been reported. The most recent capital raised was the unregistered preferred financing closed 2026-09-17, recorded as $225,000,000 net from 150,867.995 shares of Series C Non-Voting Convertible Preferred Stock.